Endocrinology, Vol 133, 2690-2695, Copyright © 1993 by Endocrine Society

ARTICLES

Activation of ovarian sympathetic nerves in polycystic ovary syndrome

HE Lara, JL Ferruz, S Luza, DA Bustamante, Y Borges and SR Ojeda
Department of Biochemistry and Molecular Biology, Faculty of Chemistry and Pharmaceutical Sciences, University of Chile, Santiago.

Polycystic ovarian syndrome (PCOS) is one of the most common human ovarian pathologies affecting women of reproductive age. Despite extensive investigation, the etiology of PCOS remains poorly understood. Experimentally, a PCO-like syndrome can be induced in rodents by a single dose of the long-acting estrogen, estradiol valerate (EV). We have used this model to examine the possibility that PCOS is associated with derangement of the sympathetic control of the ovary. The release of newly incorporated norepinephrine (NE) from ovarian nerve terminals in response to transmural stimulation of the gland increased significantly before the formation of cysts (30 days after EV injection) and remained elevated at the time when cysts form (60 days). The increase in evoked NE release was accompanied by an augmented NE content and enhanced incorporation of [3H]NE into ovarian tissue; both of these changes had been initiated by 30 days after EV treatment and became unambiguous at the time of cyst formation. The overall increase in ovarian sympathetic outflow suggested by these alterations in catecholamine homeostasis was accompanied by a thecal cell-interstitial tissue selective down-regulation of beta-adrenergic receptors; the beta-adrenergic receptor concentration in these sympathetically innervated ovarian compartments was significantly lower in PCO than during the estrous phase of the estrous cycle, a time at which the beta-adrenergic receptor concentration reaches its lowest levels in normal cycling ovaries. Tyrosine hydroxylase activity was found to increase only when expressed per mg ovary, but not in absolute terms (i.e. per total ovary), suggesting regulation of enzyme activity by the enhanced catecholamine content. The results demonstrate that an activation of the sympathetic neurons innervating the ovary precedes the development of cysts in EV-induced PCOS and raise the possibility that a derangement of sympathetic inputs to the ovary contributes to the etiology of PCOS.

This article has been cited by other articles:

				M. Greiner, A. Paredes, V. Rey-Ares, S. Saller, A. Mayerhofer, and H. E. Lara Catecholamine Uptake, Storage, and Regulated Release by Ovarian Granulosa Cells Endocrinology, October 1, 2008; 149(10): 4988 - 4996. [Abstract] [Full Text] [PDF]

				M. P. Bernuci, R. E. Szawka, C. V. V. Helena, C. M. Leite, H. E. Lara, and J. A. Anselmo-Franci Locus Coeruleus Mediates Cold Stress-Induced Polycystic Ovary in Rats Endocrinology, June 1, 2008; 149(6): 2907 - 2916. [Abstract] [Full Text] [PDF]

				R. Sotomayor-Zarate, M. Dorfman, A. Paredes, and H. E. Lara Neonatal Exposure to Estradiol Valerate Programs Ovarian Sympathetic Innervation and Follicular Development in the Adult Rat Biol Reprod, April 1, 2008; 78(4): 673 - 680. [Abstract] [Full Text] [PDF]

				Y. B. Sverrisdottir, T. Mogren, J. Kataoka, P. O. Janson, and E. Stener-Victorin Is polycystic ovary syndrome associated with high sympathetic nerve activity and size at birth? Am J Physiol Endocrinol Metab, March 1, 2008; 294(3): E576 - E581. [Abstract] [Full Text] [PDF]

				M. Ricu, A. Paredes, M. Greiner, S. R. Ojeda, and H. E. Lara Functional Development of the Ovarian Noradrenergic Innervation Endocrinology, January 1, 2008; 149(1): 50 - 56. [Abstract] [Full Text] [PDF]

				L. Manneras, S. Cajander, A. Holmang, Z. Seleskovic, T. Lystig, M. Lonn, and E. Stener-Victorin A New Rat Model Exhibiting Both Ovarian and Metabolic Characteristics of Polycystic Ovary Syndrome Endocrinology, August 1, 2007; 148(8): 3781 - 3791. [Abstract] [Full Text] [PDF]

				C. Parra, J. L Fiedler, S L. Luna, M. Greiner, V. Padmanabhan, and H. E Lara Participation of vasoactive intestinal polypeptide in ovarian steroids production during the rat estrous cycle and in the development of estradiol valerate-induced polycystic ovary Reproduction, January 1, 2007; 133(1): 147 - 154. [Abstract] [Full Text] [PDF]

				L. Manni, A. Holmang, S. Cajander, T. Lundeberg, L. Aloe, and E. Stener-Victorin Effect of anti-NGF on ovarian expression of {alpha}1- and beta2-adrenoceptors, TrkA, p75NTR, and tyrosine hydroxylase in rats with steroid-induced polycystic ovaries Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2006; 290(3): R826 - R835. [Abstract] [Full Text] [PDF]

				A. Rosa-e-Silva, M. A. Guimaraes, V. Padmanabhan, and H. E. Lara Prepubertal Administration of Estradiol Valerate Disrupts Cyclicity and Leads to Cystic Ovarian Morphology during Adult Life in the Rat: Role of Sympathetic Innervation Endocrinology, October 1, 2003; 144(10): 4289 - 4297. [Abstract] [Full Text] [PDF]

				M. Dorfman, S. Arancibia, J.L. Fiedler, and H.E. Lara Chronic Intermittent Cold Stress Activates Ovarian Sympathetic Nerves and Modifies Ovarian Follicular Development in the Rat Biol Reprod, June 1, 2003; 68(6): 2038 - 2043. [Abstract] [Full Text] [PDF]

				A. Mayerhofer, S. Fritz, R. Grünert, S. L. Sanders, D. M. Duffy, S. R. Ojeda, and R. L. Stouffer D1-Receptor, DARPP-32, and PP-1 in the Primate Corpus Luteum and Luteinized Granulosa Cells: Evidence for Phosphorylation of DARPP-32 by Dopamine and Human Chorionic Gonadotropin J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4750 - 4757. [Abstract] [Full Text]

				E. Stener-Victorin, T. Lundeberg, U. Waldenström, L. Manni, L. Aloe, S. Gunnarsson, and P. O. Janson Effects of Electro-Acupuncture on Nerve Growth Factor and Ovarian Morphology in Rats with Experimentally Induced Polycystic Ovaries Biol Reprod, November 1, 2000; 63(5): 1497 - 1503. [Abstract] [Full Text]

				H. E. Lara, G. A. Dissen, V. Leyton, A. Paredes, H. Fuenzalida, J. L. Fiedler, and S. R. Ojeda An Increased Intraovarian Synthesis of Nerve Growth Factor and Its Low Affinity Receptor Is a Principal Component of Steroid-Induced Polycystic Ovary in the Rat Endocrinology, March 1, 2000; 141(3): 1059 - 1072. [Abstract] [Full Text] [PDF]

				G. A. Dissen, H. E. Lara, V. Leyton, A. Paredes, D. F. Hill, M. E. Costa, A. Martinez-Serrano, and S. R. Ojeda Intraovarian Excess of Nerve Growth Factor Increases Androgen Secretion and Disrupts Estrous Cyclicity in the Rat Endocrinology, March 1, 2000; 141(3): 1073 - 1082. [Abstract] [Full Text] [PDF]

				H. Wahrenberg, I. Ek, S. Reynisdottir, K. Carlström, A. Bergqvist, and P. Arner Divergent Effects of Weight Reduction and Oral Anticonception Treatment on Adrenergic Lipolysis Regulation in Obese Women with the Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 2182 - 2187. [Abstract] [Full Text]

				A. Mayerhofer, H. C. Hemmings Jr., G. L. Snyder, P. Greengard, S. Boddien, U. Berg, and C. Brucker Functional Dopamine-1 Receptors and DARPP-32 Are Expressed in Human Ovary and Granulosa Luteal Cells in Vitro J. Clin. Endocrinol. Metab., January 1, 1999; 84(1): 257 - 264. [Abstract] [Full Text]